The case for selection at CCR5-Delta32.

The case for selection at CCR5-Delta32.

The C-C chemokine receptor 5, 32 base-pair deletion (CCR5-Delta32) allele confers strong resistance to infection by the AIDS virus HIV. Previous studies have suggested that CCR5-Delta32 arose within the past 1,000 y and rose to its present high frequency (5%-14%) in Europe as a result of strong posi...

Full description

Bibliographic Details
Main Authors:	Pardis C Sabeti, Emily Walsh, Steve F Schaffner, Patrick Varilly, Ben Fry, Holli B Hutcheson, Mike Cullen, Tarjei S Mikkelsen, Jessica Roy, Nick Patterson, Richard Cooper, David Reich, David Altshuler, Stephen O'Brien, Eric S Lander
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2005-11-01
Series:	PLoS Biology
Online Access:	http://europepmc.org/articles/PMC1275522?pdf=render

Similar Items

The case for selection at CCR5-Delta32.
Published: (2005-11-01)

The frequency of CCR5 promoter polymorphisms and CCR5 32 mutation in Iranian populations
by: Mohammad Zare-Bidaki, et al.
Published: (2015-04-01)

Prevalence of CCR5delta32 in Northeastern Iran
by: Amir Tajbakhsh, et al.
Published: (2019-11-01)

Frequency of CCR5delta32 in Brazilian populations
by: A.E. Vargas, et al.
Published: (2006-03-01)

Clinical significance of the CCR5delta32 allele in hepatitis C.
by: Isabelle Morard, et al.
Published: (2014-01-01)

Direct Identification of Hundreds of Expression-Modulating Variants using a Multiplexed Reporter Assay
by: Park, Daniel S., et al.
Published: (2018)

Distribution of the CCR5delta32 allele (gene variant CCR5) in Rondônia, Western Amazonian region, Brazil
by: Josileide Duarte de Farias, et al.
Published: (2012-01-01)

The geographic spread of the CCR5 Delta32 HIV-resistance allele.
by: John Novembre, et al.
Published: (2005-11-01)

Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation.
by: Duncan, S, et al.
Published: (2005)

Frequency of CCR5Δ32 allele in healthy Bosniak population.
by: Grażyna Adler, et al.
Published: (2014-08-01)

The frequency of allele CCR5Δ32 in a Serbian population
by: Đorđević Valentina, et al.
Published: (2013-01-01)

CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.
by: Djin-Ye Oh, et al.
Published: (2008-01-01)

HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
by: Gupta, R, et al.
Published: (2019)

Pleiotropy Complicates Human Gene Editing: CCR5Δ32 and Beyond
by: Ting Li, et al.
Published: (2019-07-01)

CCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5
by: Dirk Lassner, et al.
Published: (2018-09-01)

Sustained HIV-1 remission following CCR5D32/D32 allogeneic haematopoietic stem cell transplantation
by: Gupta, R, et al.
Published: (2019)

The Latitude Wise Prevalence of the CCR5-Δ32-HIV Resistance Allele in India
by: Bhatnagar I, et al.
Published: (2009-01-01)

Is CCR5-Δ32 mutation associated with diabetic nephropathy in type 2 diabetes?
by: Arababadi Mohammad, et al.
Published: (2009-01-01)

Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus.
by: Iversen, A, et al.
Published: (2003)

Association of the <it>CCR5</it>Δ32 variant with juvenile idiopathic arthritis in a meta-analysis
by: Toes REM, et al.
Published: (2011-09-01)

Evaluation of prevalence of  32 mutation in CCR5 gene in breast cancer patients in Rafsanjan city
by: Mohammad Kazemi Arababadi, et al.
Published: (2009-01-01)

Evaluation of CCR5Δ32 Polymorphism in Patients with Systemic Lupus Erythematosus and Healthy Individuals
by: Zahra Heydarifard, et al.
Published: (2018-03-01)

Association of CCR5Δ32 Deletion and Human Cytomegalovirus Infection With Colorectal Cancer in Tunisia
by: Hanen Chelbi, et al.
Published: (2021-12-01)

What makes us human?
by: Mikkelsen, Tarjei Sigurd
Published: (2010)

Dual effect of CCR5 Δ32 gene deletion in HIV-1-infected patients [2]
by: Garred, P, et al.
Published: (1996)

CCR5D32 mutation in three Brazilian populations of predominantly Sub-Saharan African ancestry
by: Mônica W.P. Carvalho, et al.
Published: (2004-01-01)

Detecting recent positive selection in the human genome from haplotype structure.
by: Sabeti, P, et al.
Published: (2002)

Implicación del alelo CCR5-Δ32 en la progresión clínica de pacientes VIH-1+ en Yucatán, México CCR5-Δ32 allele involvement in the clinical evolution of HIV1+ patients in Yucatán, Mexico
by: Nina Valadez-González, et al.
Published: (2011-12-01)

Mammalian comparative genomics and epigenomics
by: Mikkelsen, Tarjei Sigurd, 1978-
Published: (2010)

CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
by: Jan Korbecki, et al.
Published: (2020-10-01)

Clinical observation of an HIV-infected patient heterozygous for the mutant allele of the CCR5 del 32 chemokine receptor
by: Z. I. Akhmedjanova, et al.
Published: (2021-07-01)

Detection of CCR5Δ32 Mutant Alleles in Heterogeneous Cell Mixtures Using Droplet Digital PCR
by: Alyona Sorokina, et al.
Published: (2022-02-01)

Mutation of CCR5 Delta 32 in Umbilical Cord Blood Samples: Future Potential for HIV-1 Cure
by: Vinayak Virupaksh Kedage, et al.
Published: (2020-05-01)

CCR2-64I allele and genotype association with delayed AIDS progression in African women
by: Anzala, A, et al.
Published: (1998)

Human genome sequence variation and the influence of gene history, mutation and recombination.
by: Reich, D, et al.
Published: (2002)

An integrated map of genetic variation from 1,092 human genomes
by: Altshuler, David, et al.
Published: (2014)

Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
by: Herman D. Lim, et al.
Published: (2021-04-01)

CCR5 Delta 32 polymorphism in inflammatory bowel disease: Further association with ulcerative colitis and with primary sclerosing cholangitis.
by: Satsangi, J, et al.
Published: (2000)

Honduras HIV cohort: HLA class I and CCR5-Δ32 profiles and their associations with HIV disease outcome
by: Humberto Valenzuela-Ponce, et al.
Published: (2023-12-01)

Pushing it back. Dating the CCR5–32 bp deletion to the Mesolithic in Sweden and its implications for the Meso\Neo transition
by: Kerstin Lidén, et al.
Published: (2006-12-01)